These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 31356849)

  • 1. microRNA dysregulation in neurodegenerative diseases: A systematic review.
    Juźwik CA; S Drake S; Zhang Y; Paradis-Isler N; Sylvester A; Amar-Zifkin A; Douglas C; Morquette B; Moore CS; Fournier AE
    Prog Neurobiol; 2019 Nov; 182():101664. PubMed ID: 31356849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.
    Nguyen TPN; Kumar M; Fedele E; Bonanno G; Bonifacino T
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of miR-137 in Neurodegenerative Disorders.
    Bodai L; Borosta R; Ferencz Á; Kovács M; Zsindely N
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-223 protects neurons from degeneration in experimental autoimmune encephalomyelitis.
    Morquette B; Juźwik CA; Drake SS; Charabati M; Zhang Y; Lécuyer MA; Galloway DA; Dumas A; de Faria Junior O; Paradis-Isler N; Bueno M; Rambaldi I; Zandee S; Moore C; Bar-Or A; Vallières L; Prat A; Fournier AE
    Brain; 2019 Oct; 142(10):2979-2995. PubMed ID: 31412103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement.
    Hoss AG; Labadorf A; Latourelle JC; Kartha VK; Hadzi TC; Gusella JF; MacDonald ME; Chen JF; Akbarian S; Weng Z; Vonsattel JP; Myers RH
    BMC Med Genomics; 2015 Mar; 8():10. PubMed ID: 25889241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA abundance is altered in synaptoneurosomes during prion disease.
    Boese AS; Saba R; Campbell K; Majer A; Medina S; Burton L; Booth TF; Chong P; Westmacott G; Dutta SM; Saba JA; Booth SA
    Mol Cell Neurosci; 2016 Mar; 71():13-24. PubMed ID: 26658803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA: Basic concepts and implications for regeneration and repair of neurodegenerative diseases.
    Saraiva C; Esteves M; Bernardino L
    Biochem Pharmacol; 2017 Oct; 141():118-131. PubMed ID: 28709951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature.
    Redenšek Trampuž S; Vogrinc D; Goričar K; Dolžan V
    Front Mol Neurosci; 2023; 16():1123955. PubMed ID: 37008787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3.
    Shioya M; Obayashi S; Tabunoki H; Arima K; Saito Y; Ishida T; Satoh J
    Neuropathol Appl Neurobiol; 2010 Jun; 36(4):320-30. PubMed ID: 20202123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common signatures of differential microRNA expression in Parkinson's and Alzheimer's disease brains.
    Dobricic V; Schilling M; Farkas I; Gveric DO; Ohlei O; Schulz J; Middleton L; Gentleman SM; Parkkinen L; Bertram L; Lill CM
    Brain Commun; 2022; 4(6):fcac274. PubMed ID: 36382223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs underlying memory deficits in neurodegenerative disorders.
    Hernandez-Rapp J; Rainone S; Hébert SS
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Feb; 73():79-86. PubMed ID: 27117821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA target prediction in glaucoma.
    Romano GL; Platania CB; Forte S; Salomone S; Drago F; Bucolo C
    Prog Brain Res; 2015; 220():217-40. PubMed ID: 26497793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington's Disease Stages.
    Christodoulou CC; Papanicolaou EZ
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNAs and Neurodegenerative Diseases.
    Qiu L; Tan EK; Zeng L
    Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of microRNAs in neurodegenerative diseases: a review.
    Li S; Lei Z; Sun T
    Cell Biol Toxicol; 2023 Feb; 39(1):53-83. PubMed ID: 36125599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in Neurodegenerative Diseases.
    Quinlan S; Kenny A; Medina M; Engel T; Jimenez-Mateos EM
    Int Rev Cell Mol Biol; 2017; 334():309-343. PubMed ID: 28838542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
    Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients.
    Haenisch S; Zhao Y; Chhibber A; Kaiboriboon K; Do LV; Vogelgesang S; Barbaro NM; Alldredge BK; Lowenstein DH; Cascorbi I; Kroetz DL
    Neurobiol Dis; 2015 May; 77():127-40. PubMed ID: 25766675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated microRNAs in neurodegenerative disorders.
    Lau P; de Strooper B
    Semin Cell Dev Biol; 2010 Sep; 21(7):768-73. PubMed ID: 20080199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.